David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
601
DELISTED
Amicus Therapeutics
FOLD
| $26.8M | 0.03% |
2,147,403
+1,146,777
| +115% | +$14.6M |
|
602
NCR Voyix
VYX
$1.1B
| $26.7M | 0.03% |
1,400,317
-186,560
| -12% | -$3.47M |
|
|
AIV
603
Aimco
AIV
$378M
| $26.7M | 0.03% |
4,001,487
+2,418,159
| +153% | +$16.2M |
|
|
MRC
604
DELISTED
MRC Global
MRC
| $26.6M | 0.03% |
1,553,748
-596,153
| -28% | -$10M |
|
605
Teva Pharmaceuticals
TEVA
$43B
| $26.6M | 0.03% |
2,877,537
+2,671,960
| +1,300% | +$32.2M |
|
606
Williams-Sonoma
WSM
$28B
| $26.6M | 0.03% |
817,034
-15,380
| -2% | -$441K |
|
|
TVTY
607
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $26.5M | 0.03% |
1,611,396
-784,750
| -33% | -$15.1M |
|
608
CALL
Advanced Micro Devices
AMD
$746B
| $26.4M | 0.03% |
870,100
-106,800
| -11% | -$3.05M |
|
609
CALL
American Airlines Group
AAL
$9.02B
| $26.4M | 0.03% |
809,800
-122,700
| -13% | -$3.96M |
|
610
CALL
General Motors
GM
$76.3B
| $26.4M | 0.03% |
685,200
-404,700
| -37% | -$15.2M |
|
611
CALL
Kraft Heinz
KHC
$30.4B
| $26.4M | 0.03% |
850,500
+518,000
| +156% | +$16.3M |
|
612
Planet Fitness
PLNT
$4.07B
| $26.4M | 0.03% |
364,325
-49,736
| -12% | -$3.75M |
|
613
Workiva
WK
$4.07B
| $26.3M | 0.03% |
453,069
+154,746
| +52% | +$8.29M |
|
614
Trinity Industries
TRN
$2.37B
| $26.3M | 0.03% |
1,267,304
+284,942
| +29% | +$6.06M |
|
|
EQC
615
DELISTED
Equity Commonwealth
EQC
| $26.2M | 0.03% |
805,669
+341,800
| +74% | +$11.1M |
|
616
CALL
PepsiCo
PEP
$197B
| $26M | 0.03% |
198,300
-46,000
| -19% | -$5.9M |
|
617
Progress Software
PRGS
$1.78B
| $26M | 0.03% |
595,180
+5,593
| +0.9% | +$242K |
|
618
Kulicke & Soffa
KLIC
$4.37B
| $25.9M | 0.03% |
1,150,548
-74,535
| -6% | -$1.64M |
|
|
HMSY
619
DELISTED
HMS Holdings Corp.
HMSY
| $25.8M | 0.03% |
797,207
-314,615
| -28% | -$9.62M |
|
620
Henry Schein
HSIC
$9.98B
| $25.8M | 0.03% |
368,519
+229,985
| +166% | +$15.2M |
|
621
Nomad Foods
NOMD
$1.69B
| $25.6M | 0.03% |
1,200,818
+882,812
| +278% | +$18.5M |
|
|
CERN
622
DELISTED
Cerner Corp
CERN
| $25.6M | 0.03% |
349,803
+170,389
| +95% | +$11.5M |
|
623
Heron Therapeutics
HRTX
$61.3M
| $25.5M | 0.03% |
1,372,291
-99,305
| -7% | -$1.98M |
|
624
DuPont de Nemours
DD
$18.5B
| $25.4M | 0.03% |
269,092
-196,429
| -42% | -$23.5M |
|
625
CenterPoint Energy
CNP
$25.8B
| $25.3M | 0.03% |
885,174
+470,850
| +114% | +$14M |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.